Clinical Trials Directory

Trials / Unknown

UnknownNCT01297816

Evaluation of Neuroprotective Effect of Minocycline

Evaluation of Minocycline Neuro Protective Role in Retinal Detachment Surgery

Status
Unknown
Phase
Phase 2
Study type
Interventional
Enrollment
Sponsor
Shahid Beheshti University of Medical Sciences · Academic / Other
Sex
All
Age
8 Years
Healthy volunteers
Not accepted

Summary

This process appears as a incredible and progressive event that will not stop till reattachment of RPE and neurosensory retina happened . Process of degeneration begins from first hours of RD (Retinal Detachment) establishment Neuroprotection of photoreceptor following RD is a novel and debatable discussion encountered in recent years . How to stop this phenomena and neuroprotective agent role in this issue are a new interest of researcher. In the study the investigators are planning to perform a clinical trial to demonstrate the minocycline neuroprotective effect in a double blind design as this impact has been implicated previously in a animal study

Conditions

Interventions

TypeNameDescription
DRUGplacebo100mg,BD, fo three month
DRUGMinocycline100mg

Timeline

Start date
2010-12-01
Primary completion
2010-12-01
Completion
2011-04-01
First posted
2011-02-17
Last updated
2011-02-17

Locations

1 site across 1 country: Iran

Source: ClinicalTrials.gov record NCT01297816. Inclusion in this directory is not an endorsement.

Evaluation of Neuroprotective Effect of Minocycline (NCT01297816) · Clinical Trials Directory